ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 2057

Clinical Features of Autoimmune Uveitis and Associated Factors with Reactivation Subtype Presentation from a Peruvian Multidisciplinary Reference Center

Hugo Madariaga.Ch1, Valery Ascuña2 and RV, Gamboa-Cardenas3, and Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas , Universidad Científica del Sur, 1Clínica del Sur Sanna. Arequipa-Perú, Arequipa, Peru, 2Oftalmosalud Clinical Center. Arequipa-Perú, Arequipa, Peru, 3Universidad Científica del Sur, Lima, Lima, Peru

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, Eye Disorders, Spondyloarthropathies

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Miscellaneous Rheumatic & Inflammatory Diseases Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: To determine clinical features of autoimmune uveitis (AU) and the associated factors with the reactivation subtype 

Methods: A transversal analysis from single center cohort (ophthalmologic/rheumatologic outpatients’ clinic) between 2018 to 2023. Presence of AU and its clinical  subtype (acute, chronic or reactivation) were defined according with the Standardization of Uveitis Nomenclature (SUN) Project (1). Patients with at least 18 years (or with a previous parents IC in child) and with no infectious suspicious or pregnant, were included. Sociodemographic and clinical features were desfined by descriptive statistics. A multivariable binary regression model was performed to determine associated factors with AU reactivation subtype adjusted by gender, age, education, disease duration, uveitis localization, idiopathic versus secondary causes, type of autoimmune systemic disease (ASD) associated such as spondylarthritis, vasculitis -and other vessel disease, rheumatoid arthritis, and idiopathic juvenile arthritis, and the treatment prescribed [glucocorticoids (GCs) dose , GCs pulse therapy , c-DMARDs and b-DMARDs].

Results: From 459 patients, 120 were included; most patients were females 65(54.17%); Only 20 (16.67%) patients had idiopathic AU. Spondylarthritis was the most frequent ASD in the secundary AU: 49 (40.83%). Reactivation was the most frequent AU subtype :56 (46.67%). In the MV analysis variables associated with reactivation subtype were the use of intermediate/higher GCs dose (OR=26.465; p=0.001), GCs pulse therapy (OR=11.10; p=0.002) and b-DMARDs use (OR=0.040; p< 0.001) (Table 1)

Conclusion: In our AU cohort anterior uveitis and the presence of ASD (specially spondylarthritis) intead of idiophatic uveitis, were frequent. The AU reactivation subtype was associated with a more intensive treatment prescription.
(1)
Trusko B, Methods Inf Med. 2013;52(3):259-65, S1-6.

Supporting image 1


Disclosures: H. Madariaga.Ch: None; V. Ascuña: None; R. Gamboa-Cardenas: None.

To cite this abstract in AMA style:

Madariaga.Ch H, Ascuña V, Gamboa-Cardenas R. Clinical Features of Autoimmune Uveitis and Associated Factors with Reactivation Subtype Presentation from a Peruvian Multidisciplinary Reference Center [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/clinical-features-of-autoimmune-uveitis-and-associated-factors-with-reactivation-subtype-presentation-from-a-peruvian-multidisciplinary-reference-center/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-features-of-autoimmune-uveitis-and-associated-factors-with-reactivation-subtype-presentation-from-a-peruvian-multidisciplinary-reference-center/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology